We are the combination of four hospitals: the General Hospital, the Children’s Hospital, the Women’s Hospital and the Traumatology, Rehabilitation and Burns Hospital. We are part of the Vall d’Hebron Barcelona Hospital Campus: a world-leading health park where healthcare plays a crucial role.
Below we will list the departments and units that form part of Vall d’Hebron Hospital and the main diseases that we treat. We will also make recommendations based on advice backed up by scientific evidence that has been shown to be effective in guaranteeing well-being and quality of life.
Would you like to know what your stay at Vall d'Hebron will be like? Here you will find all the information.
The commitment of Vall d'Hebron University Hospital to innovation allows us to be at the forefront of medicine, providing first class care adapted to the changing needs of each patient.
The study aims to investigate how excess body fat alters the number and function of T lymphocytes, leading to a greater predisposition to infectious diseases.
The project, recently awarded to Dr. Ana Ciscar Belles and Dr. Ramon Vilallonga Puy, both based in the General Surgery Department of Vall d’Hebron University Hospital, will be funded by FUNSECO. Its main objective is to precisely define the effects of obesity on the adaptive immunity of obese patients and, more specifically, on the function of T lymphocytes.
Numerous epidemiological studies show that obesity is associated with a greater predisposition to infectious diseases, and that these diseases tend to be more severe in obese individuals. This was observed during the COVID-19 pandemic, where data demonstrated that infection of obese patients with the SARS-CoV-2 virus significantly increased the risk of hospitalization and the need for mechanical ventilation, greatly raising the mortality rate.
Despite the evidence, the reason why obese individuals have a reduced ability to respond to pathogens is still unknown. It appears to be associated with a deficient function of various cellular components of their immune system. This study specifically aims to investigate how excess body fat alters the number and function of T lymphocytes. These cells are a diverse population within the immune system responsible for modulating the host’s response to pathogens and participating in the elimination of cells infected by viruses or other microorganisms.
The study will identify the various populations of T cells in the blood and adipose tissue of obese and normal-weight patients, and will analyze their polarization and ability to secrete cytokines when activated in vitro. This will allow researchers to determine the functional state of T lymphocytes.
The study will be conducted jointly by the Endocrine, Metabolic, and Bariatric Surgery Unit of Vall d’Hebron University Hospital, under the direction of Dr. Vilallonga and Dr. Ciscar, and the Metabolism and Obesity Laboratory of the Vall d’Hebron Research Institute, led by Dr. Villena. It will also involve the collaboration of Dr. Ciudin, head of the hospital’s Comprehensive Obesity Treatment Unit.
General and Digestive Surgery, General Hospital
By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to web@vallhebron.cat, clearly stating the subject as "Exercising of Data Protection Rights". Operated by: Hospital Universitari Vall d'Hebron - Institut Català de la Salut. Purpose: Manage the user’s contact information. Legitimisation: Express acceptance of the privacy policy. Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use. Source: The interested party themselves.